Please login to the form below

Alexion Pharmaceuticals

This page shows the latest Alexion Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

BMS pledges $300m to tackle health inequity and improve diversity

Earlier this month, Alexion Pharmaceuticals appointed its first chief diversity officer, with Uzair Qadeer taking on the role after serving as head of enterprise partnerships at the company.

Latest news

Shire links with US hospital for rare disease research

It already has a rare and complex disease collaboration with Alexion Pharmaceuticals - which it describes as a "model for how industry and academia can better work together to bring health innovations
Assessing drugs for ultra-rare conditions in the UK

Alexion’s Soliris has become the first drug to pass through NICE’s new highly specialised technology process. ... No quick solution. Jon Beauchamp, business unit leader PNH/aHUS at Alexion Pharmaceuticals, told PME: “It's certainly been a very
Alexion begins work on new global headquarters

From left: New Haven Mayor John DeStefano, Sen. Richard Blumenthal, Governor Dan Malloy, Alexion CEO Leonard Bell, Rep. ... Alexion Pharmaceuticals has broken ground on the site for its new global headquarters in New Haven, Connecticut.
PDL BioPharma CEO will quit despite being cleared of misconduct

PDLs litigation with Alexion Pharmaceuticals. ... Link is chairman of Alexion, while PDL has filed a patent infringement lawsuit against the company.

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest Intelligence

Deal Watch table for January 2014

144. Moderna Therapeutics/ Alexion Pharmaceuticals. Exclusive discovery and development. Messenger RNA (mRNA) therapeutics in rare diseases for 10 product options. ... 100. Cancer Prevention Pharmaceuticals/ Zeria Tillotts Pharma. Exclusive licensing

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals

Prior to CRISPR, he worked as head of translational medicine at Alexion Pharmaceuticals, and also served as chief medical officer of Taligen Therapeutics. ... Cagnoni, chief executive officer of Rubius. Titan Pharmaceuticals. Kate DeVarney has joined
Amryt Pharma appoints Jordi Casals as head of Europe

He joins the company from Aegerion Pharmaceuticals. Amryt Pharma, a company focused on treatments for rare and orphan diseases, has appointed Jordi Casals as the biopharma’s head of Europe. ... Prior to this, he worked for eight years at Alexion
Alexion Pharmaceuticals adds to its board

Judith Reinsdorf recently worked at Johnson Controls. Alexion Pharmaceuticals has appointed Judith Reinsdorf to its board of directors following her role as executive vice president and general counsel of Johnson Controls. ... David Brennan, chairman of
Belgium's TiGenix appoints Dr Gregory Gordon

Dr Gordon joins TiGenix from Nestlé Health Science, where he was global clinical affairs lead, gastrointestinal health and prior to that he has worked at Stealth BioTherapeutics, Ironwood Pharmaceuticals and Parexel. ... Meanwhile, Valles-Sukkar arrives
Minoryx Therapeutics adds to board of directors

Dr Nicaise founded Clinical Regulatory Services, a biotech-focused advisory service, in 2014, having previously served as senior vice president of strategic development and global regulatory affairs at Alexion Pharmaceuticals from

More from appointments
Approximately 1 fully matching, plus 8 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping: Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much: Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website: You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...